83 results
8-K
ATXS
Astria Therapeutics Inc
25 Mar 24
Other Events
7:37am
of words such as, but not limited to, “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “goals,” “intend,” “may,” “might,” “plan
424B5
ATXS
Astria Therapeutics Inc
4 Mar 24
Prospectus supplement for primary offering
5:20pm
regarding the timing, nature, goals and results of the ALPHA-STAR Phase 1b/2 clinical trial of STAR-0215, including the expected timing of release … in additional indications;
our goals and visions for the STAR-0310 program;
our expectations regarding our ability to expand our pipeline;
the potential
424B5
udx0ofxsgsccprewe i4
31 Jan 24
Prospectus supplement for primary offering
8:59am
8-K
EX-99.1
9psa2 4erp
13 Nov 23
Astria Therapeutics Reports Third Quarter Financial Results and Provides a Corporate Update
8:06am
424B5
fgios4 3dgwitj
12 Oct 23
Prospectus supplement for primary offering
5:01pm
8-K
EX-99.2
nlum9re
11 Oct 23
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
5:14pm
8-K
a857mm 5citqo0rd45s
11 Oct 23
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
5:14pm
8-K
EX-99.1
nyxj7r673o sj
11 Oct 23
Astria Therapeutics Announces Exclusive Worldwide License Agreement with Ichnos Sciences for OX40 Portfolio
5:14pm
424B5
2l9giaxhpgrn exf1
15 Dec 22
Prospectus supplement for primary offering
5:16pm